Study of XL647 Administered Orally Daily to Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00336765
Recruitment Status : Completed
First Posted : June 14, 2006
Last Update Posted : October 18, 2011
Information provided by (Responsible Party):
Kadmon Corporation, LLC

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2010
  Study Completion Date : September 2010